Webinar | January 29, 2019

Right-To-Try Or Right-to-Ask? Understanding Right-To-Try And FDA's Expanded Access

Source: Rho

Right-to-Try has been in the news a lot recently, but what does it actually mean for product sponsors? This webinar explores both Right-to-Try legislation and existing Expanded Access Programs, including understanding sponsor responsibilities under these programs and when products may be eligible for these programs, evaluating options such as treatment protocols, treatment INDs, and emergency use, and discussing development risks associated with participation in these programs.